Cardiovascular Systems to Present at 10th Annual JMP Securities Research Conference on Tuesday, May 10
May 05 2011 - 11:58AM
Business Wire
Cardiovascular Systems, Inc. (Nasdaq: CSII), a medical device
company developing and commercializing innovative, interventional
treatment systems for vascular disease, will present at the 10th
Annual JMP Securities Research Conference in San Francisco on
Tuesday, May 10, 2011. President and Chief Executive Officer David
L. Martin and Chief Financial Officer Laurence L. Betterley will
provide an overview of the company and its initiatives.
WHEN:
10th Annual JMP Securities Research
Conference
Tuesday, May 10; 1:30 p.m. PT The Ritz-Carlton San Francisco
WEBCAST:
To listen to a live webcast of the
presentation, go to the investor information section of the
company’s website, www.csi360.com, and click on the webcast
icon.
If you have any difficulty accessing the webcast, please
contact
Mick Forgey: (612) 455-1789;
mforgey@psbpr.com
About Cardiovascular Systems, Inc.Cardiovascular Systems,
Inc., based in St. Paul, Minn., is a medical device company focused
on developing and commercializing innovative solutions for treating
vascular and coronary disease. The company’s Stealth 360°™,
Diamondback 360® and Diamondback Predator 360® Orbital PAD Systems
treat calcified and fibrotic plaque in arterial vessels throughout
the leg in a few minutes of treatment time, and address many of the
limitations associated with existing surgical, catheter and
pharmacological treatment alternatives. The U.S. FDA granted 510(k)
clearance for the use of the Diamondback 360° in August 2007 and
for the Stealth 360° in March 2011. To date, more than 46,000 PAD
procedures have been performed using the Diamondback 360° in
leading institutions across the United States.
CSI has also commenced its ORBIT II Investigational Device
Exemption clinical trial to evaluate the safety and effectiveness
of its Diamondback 360° System in treating coronary arteries. The
coronary system is under clinical investigation and is currently
not commercially available in the United States.
For more information, visit the company’s website at
www.csi360.com.
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Jul 2023 to Jul 2024